Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Saelens, Xavier" or (type exact bookEditor and editor="Saelens, Xavier")

Mark
- journalArticle
- open access
The Role of M2e in the Development of Universal Influenza Vaccines

Xavier Saelens

(2019) The Journal of Infectious Diseases.
Mark
- journalArticle
- open access
Vaccine options for influenza: thinking small

Bert Schepens, Dorien De Vlieger and Xavier Saelens

(2018) Current Opinion in Immunology. 53. p.22-29
Mark
Clinical potential of prefusion RSV F-specific antibodies

Iebe Rossey (UGent) , Jason S McLellan, Xavier Saelens (UGent) and Bert Schepens (UGent)

(2018) TRENDS IN MICROBIOLOGY. 26(3). p.209-219
Mark
- journalArticle
- open access
Vaccine options for influenza: thinking small

Bert Schepens (UGent) , Dorien De Vlieger (UGent) and Xavier Saelens (UGent)

(2018) Current Opinion in Immunology. 53. p.22-29
Mark
Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice

Annasaheb Kolpe (UGent) , Bert Schepens (UGent) , Liang Ye, Peter Staeheli and Xavier Saelens (UGent)

(2018) ANTIVIRAL RESEARCH. 158. p.244-254
Mark
- journalArticle
- A1
- open access
Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein

Florencia Linero (UGent) , Claudia Sepúlveda, Ioanna Christopoulou (UGent) , Paco Hulpiau (UGent) , Luis Scolaro and Xavier Saelens (UGent)

(2018) SCIENTIFIC REPORTS. 8.
Mark
- journalArticle
Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ

Sophie Jacobs, Fanny Wavreil, Bert Schepens (UGent) , Hans Henrik Gad, Rune Hartmann, Joana Rocha-Pereira, Johan Neyts, Xavier Saelens (UGent) and Thomas Michiels

(2018) Journal of Interferon & Cytokine Research. 38(11). p.469-479
Mark
- journalArticle
- open access
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

Joanne M Langley, Lisa D MacDonald, Genevieve M Weir, Donna MacKinnon-Cameron, Lingyun Ye, Shelly McNeil, Bert Schepens (UGent) , Xavier Saelens (UGent) , Marianne M Stanford and Scott A Halperin

(2018) The Journal of Infectious Diseases. 218(3). p.378-387
Mark
- journalArticle
- A1
- open access
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Lien Van Hoecke (UGent) , Sandra Van Lint (UGent) , Kenny Roose (UGent) , Alexander Van Parys (UGent) , Peter Vandenabeele (UGent) , Johan Grooten (UGent) , Jan Tavernier (UGent) , Stefaan De Koker (UGent) and Xavier Saelens (UGent)

(2018) NATURE COMMUNICATIONS. 9.
Mark
- journalArticle
- open access
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Lien Van Hoecke, Sandra Van Lint, Kenny Roose, Alexander Van Parys, Peter Vandenabeele, Johan Grooten, Jan Tavernier, Stefaan De Koker and Xavier Saelens

(2018) Nature Communications. 9(1).

Academic Bibliography

The Role of M2e in the Development of Universal Influenza Vaccines

Vaccine options for influenza: thinking small

Clinical potential of prefusion RSV F-specific antibodies

Vaccine options for influenza: thinking small

Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in mice

Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein

Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λ

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Contents

Support

Contact